<p>Impact BioMedical Inc. shareholders have authorized key corporate actions, including a Reverse Stock Split and changes to Authorized Shares. These actions were approved on March 28, 2025. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Impact Biomedical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-027284), on December 11, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

<p>Impact BioMedical Inc. shareholders have approved key corporate actions, including a Reverse Stock Split and changes to Authorized Shares, on March 28, 2025. The full filing is available via EDGAR (Ref. ID: 0001493152-25-027284).</p>

Impact Biomedical Inc. Files Preliminary Information Statement Outlining Authorized Corporate Actions